Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

FORMA Therapeutics and Celgene form multi-year strategic alliance

April 3, 2014

Almirall acquires European rights to InDex's ulcerative colitis drug candidate

April 3, 2014

AstraZeneca and Medical Research Council establish collaboration

April 3, 2014

Anavex obtains exclusive rights to AF-710B to strengthen Alzheimer's pipeline

April 2, 2014

Clinigen acquires Savene from SpePharm

April 2, 2014

Eisai assigns Dacogen rights to Otsuka Pharmaceutical

April 1, 2014

Takeda licenses Trianni transgenic mouse antibody discovery platform

April 1, 2014

Merck & Co. licenses NanoBio's adjuvant technology for use in RSV and influenza vaccines

March 31, 2014

Xenon Pharmaceuticals and Genentech establish new pain genetics collaboration

March 28, 2014

Courtagen Life Sciences to provide genetic testing in RP-103 study

March 28, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.